Old Web
English
Sign In
Acemap
>
Paper
>
39 MK-5172: A NOVEL HCV NS3/4A PROTEASE INHIBITOR WITH POTENT ACTIVITY AGAINST KNOWN RESISTANCE MUTANTS
39 MK-5172: A NOVEL HCV NS3/4A PROTEASE INHIBITOR WITH POTENT ACTIVITY AGAINST KNOWN RESISTANCE MUTANTS
2010
Steven S. Carroll
John A. McCauley
Steven W. Ludmerer
Steven Harper
Vincenzo Summa
Michael Rowley
Michael T. Rudd
Paul J. Coleman
Nigel J. Liverton
John W. Butcher
Charles J. McIntyre
Joseph J. Romano
Kimberly J. Bush
Marco Ferrara
Benedetta Crescenzi
Alessia Petrocchi
Marcello DiFilippo
Christine Burlein
Jillian DiMuzio
Donald J. Graham
Carolyn McHale
Mark Stahlhut
Adam T. Gates
Christine Fandozzi
Nicole Trainor
Daria J. Hazuda
Joseph P. Vacca
David B. Olsen
Keywords:
Protease
Virology
Kunitz STI protease inhibitor
Mutant
NS3
Medicine
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]